Infrastructure
Designed Around Sterility. Built Around Quality.
Every detail of the KAISHA Pharma manufacturing campus has been planned with one objective—to produce pharmaceutical glass packaging that consistently meets the highest expectations of the global healthcare industry. From intelligent facility design and automated production technologies to advanced inspection systems and contamination-controlled environments, our manufacturing ecosystem is engineered to deliver quality, consistency, and confidence at every stage.
- 300,000 sq. ft.Manufacturing Campus
- DedicatedSterile & Conventional Glass Production
- AdvancedAutomation & Inspection Technologies
The campus
Building the Future of Pharmaceutical Glass Packaging
Every detail of the KAISHA Pharma manufacturing campus has been planned with one objective—to produce pharmaceutical glass packaging that consistently meets the highest expectations of the global healthcare industry. From intelligent facility design and automated production technologies to advanced inspection systems and contamination-controlled environments, our manufacturing ecosystem is engineered to deliver quality, consistency, and confidence at every stage.
At KAISHA Pharma, manufacturing is more than a production process—it is a carefully engineered ecosystem where technology, infrastructure, quality systems, and operational excellence work together to create pharmaceutical packaging solutions trusted by healthcare companies worldwide.
Located within a 25-acre manufacturing campus, our new-generation facility has been designed to support both current pharmaceutical requirements and the evolving needs of biologics, complex injectables, and next-generation drug delivery systems. Every production area has been planned to maximize operational efficiency while maintaining the highest standards of product quality, contamination control, and process reliability.
The facility combines advanced glass-forming technologies, intelligent automation, rigorous in-process controls, and modern cleanroom environments to ensure every container leaving our manufacturing lines reflects our commitment to excellence.
At a glance
Manufacturing at a Glance
-
300,000 sq. ft.
Manufacturing Campus
State-of-the-art manufacturing facility designed for large-scale pharmaceutical glass production.
-
25 acres
Integrated Campus
Strategically planned for future expansion while supporting efficient manufacturing operations.
-
Dedicated Production Zones
Separate manufacturing environments for sterile and conventional glass products to optimize operational efficiency and contamination control.
-
Automated Manufacturing
High-speed production lines designed to deliver consistent quality, repeatability, and manufacturing reliability.
-
Intelligent Inspection Systems
Multiple automated inspection technologies integrated throughout production to enhance process control and product consistency.
-
In-House ETO Sterilization
Dedicated sterilization capability providing greater process control and streamlined sterile product preparation.
How the plant is planned
Purpose-Built Manufacturing Infrastructure
Every production area has been carefully designed around the fundamental principles of pharmaceutical manufacturing: product protection, controlled environments, efficient workflows, and operational consistency.
The facility incorporates dedicated manufacturing zones, controlled personnel movement, optimized material handling pathways, and strategically positioned support areas to minimize operational risks while maximizing manufacturing efficiency.
This integrated approach enables smooth production flow from raw glass processing through forming, inspection, sterilization, packaging, and dispatch.
- 01Raw glass processing
- 02Forming
- 03Inspection
- 04Sterilization
- 05Packaging
- 06Dispatch
Contamination control
Designed for Sterile Manufacturing
Sterility begins long before a product reaches the filling line.
Our manufacturing philosophy focuses on creating environments that reduce contamination risks through intelligent facility planning, controlled cleanroom environments, optimized process flows, and automated handling technologies.
Key features include:
- 01Controlled cleanroom environments designed for pharmaceutical manufacturing
- 02Dedicated sterile production areas
- 03Optimized personnel and material movement
- 04Controlled environmental monitoring
- 05Contamination-conscious facility design
- 06Integrated support utilities for sterile operations
Automation
Automation at Every Critical Stage
Modern pharmaceutical manufacturing demands more than production capacity—it requires repeatability, precision, and data-driven process control.
KAISHA Pharma integrates advanced automation throughout the manufacturing process to improve operational consistency, reduce variability, and support efficient high-volume production.
Automation supports every stage, including:
- 01 Glass forming
- 02 Annealing
- 03 Product transfer
- 04 Inspection
- 05 Packaging
- 06 Material handling
- 07 Production monitoring
This approach enhances manufacturing reliability while allowing consistent product quality across every production batch.
The plan
Built Around Intelligent Process Flow
One of the defining characteristics of the KAISHA Pharma facility is its carefully engineered production layout.
Rather than treating manufacturing as isolated operations, every production stage has been connected through intelligent process planning that supports continuous product movement while reducing unnecessary handling.
Our manufacturing philosophy incorporates:
Inspection & sterilization
Advanced Inspection Technologies
Quality is not inspected at the end of production—it is monitored throughout the manufacturing journey.
Our manufacturing lines incorporate multiple inspection technologies to strengthen process control and improve manufacturing consistency.
These include:
-
100% X-Ray Inspection
Advanced inspection systems designed to verify critical product characteristics throughout production.
See it on Quality & Control -
Vision Inspection Systems
Automated camera-based technologies for dimensional, cosmetic, and process verification.
See it on Quality & Control -
Silicon Presence Detection
Dedicated inspection systems to verify silicone application across syringe barrels.
-
Needle Hook Blockage Detection
Camera-based inspection technology supporting syringe manufacturing quality.
-
Automated In-Process Controls
Continuous monitoring throughout production to support consistent manufacturing performance.
Sterilization Capabilities
Sterility assurance is an essential component of pharmaceutical packaging.
KAISHA Pharma incorporates in-house Ethylene Oxide (ETO) sterilization capabilities, providing greater control over sterilization processes while reducing external dependencies.
This integrated capability supports efficient processing of sterile product configurations while enhancing manufacturing flexibility and supply chain responsiveness.
How ETO sterilization is controlledScalability
Designed to Grow
The pharmaceutical industry continues to evolve, and so does KAISHA Pharma.
Our facility has been planned with long-term scalability in mind, allowing future expansion of manufacturing capacity, product offerings, and technology platforms without compromising operational efficiency.
As demand grows for biologics, ready-to-fill systems, and advanced drug delivery solutions, our infrastructure is designed to evolve alongside our customers' needs.
Why it matters
Why Our Manufacturing Philosophy Matters
Choosing a pharmaceutical packaging partner means choosing confidence.
Every investment we've made—from facility design and automation to inspection technologies and sterilization capabilities—has been driven by a single purpose: helping our customers manufacture safer medicines with greater consistency and reliability.
At KAISHA Pharma, manufacturing is not simply about producing glass containers. It is about creating a dependable foundation for the medicines that improve and save lives every day.
Experience Manufacturing Built for Tomorrow.
Discover how our advanced manufacturing ecosystem combines technology, quality, and pharmaceutical expertise to support your next generation of injectable products.